2.74
2.74 (0%)
As of Feb 14, 2025
Sight Sciences, Inc. [SGHT]
Source:
Company Overview
Sight Sciences Inc is to develop transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care – empowering people to keep seeing. We are passionate about improving patients’ lives by helping them preserve their sight. Our objective is to develop and market products for use in new treatment paradigms and to create an interventional mindset in eyecare whereby our products may be used in procedures which supplant conventional outdated approaches.
| Country | United States |
| Headquarters | menlo park, california |
| Phone Number | (415) 889-0550 |
| Industry | |
| CEO | Paul Badawi |
| Website | www.sightsciences.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $79.9 |
| Operating Profit | $-50.5 |
| Net Income | $-51.5 |
| Net Cash | $-17.8 |
Profit Ratios
| Gross Margin | $68.3 |
| Operating Margin | -63.3 |
| Profit as % of Revenues | -132.6% |
| Profit as % of Assets | -33.3% |
| Profit as % of Stockholder Equity | -58.9% |
Management Effectiveness
| Return on Equity | -58.9% |
| Return on Assets | -36.1% |
| Turnover Ratio | 51.6% |
| EBITA | $-50.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $142.8 |
| Total Liabilities | $55.3 |
| Operating Cash Flow | $-22.4 |
| Investing Cash Flow | $-0.4 |
| Financing Cash Flow | $5 |
